LEMAITRE VASCULAR INC (LMAT) Stock Fundamental Analysis
NASDAQ:LMAT - US5255582018 - Common Stock
97.07 USD
+2.51 (+2.65%)
97.07 USD
0 (0%)
LMAT gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 190 industry peers in the Health Care Equipment & Supplies industry. LMAT scores excellent points on both the profitability and health parts. This is a solid base for a good stock. LMAT has a correct valuation and a medium growth rate. This makes LMAT very considerable for quality investing!
1. Profitability
1.1 Basic Checks
LMAT had positive earnings in the past year.
In the past year LMAT had a positive cash flow from operations.
Each year in the past 5 years LMAT has been profitable.
In the past 5 years LMAT always reported a positive cash flow from operatings.
1.2 Ratios
With an excellent Return On Assets value of 8.16%, LMAT belongs to the best of the industry, outperforming 91.58% of the companies in the same industry.
With an excellent Return On Equity value of 12.99%, LMAT belongs to the best of the industry, outperforming 89.47% of the companies in the same industry.
With an excellent Return On Invested Capital value of 7.70%, LMAT belongs to the best of the industry, outperforming 84.74% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for LMAT is in line with the industry average of 8.46%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.16% | ||
| ROE | 12.99% | ||
| ROIC | 7.7% |
ROA(3y)7.77%
ROA(5y)8.17%
ROE(3y)10.28%
ROE(5y)10.74%
ROIC(3y)8.26%
ROIC(5y)8.93%
1.3 Margins
Looking at the Profit Margin, with a value of 20.08%, LMAT belongs to the top of the industry, outperforming 93.68% of the companies in the same industry.
LMAT's Profit Margin has improved in the last couple of years.
LMAT has a better Operating Margin (23.34%) than 93.68% of its industry peers.
In the last couple of years the Operating Margin of LMAT has grown nicely.
LMAT's Gross Margin of 69.11% is fine compared to the rest of the industry. LMAT outperforms 77.37% of its industry peers.
In the last couple of years the Gross Margin of LMAT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.34% | ||
| PM (TTM) | 20.08% | ||
| GM | 69.11% |
OM growth 3Y0.27%
OM growth 5Y5.61%
PM growth 3Y4.76%
PM growth 5Y5.57%
GM growth 3Y1.48%
GM growth 5Y0.13%
2. Health
2.1 Basic Checks
LMAT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
LMAT has more shares outstanding than it did 1 year ago.
LMAT has more shares outstanding than it did 5 years ago.
LMAT has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 7.92 indicates that LMAT is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 7.92, LMAT belongs to the top of the industry, outperforming 88.95% of the companies in the same industry.
LMAT has a debt to FCF ratio of 3.21. This is a good value and a sign of high solvency as LMAT would need 3.21 years to pay back of all of its debts.
LMAT's Debt to FCF ratio of 3.21 is amongst the best of the industry. LMAT outperforms 86.84% of its industry peers.
LMAT has a Debt/Equity ratio of 0.46. This is a healthy value indicating a solid balance between debt and equity.
LMAT has a Debt to Equity ratio (0.46) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.46 | ||
| Debt/FCF | 3.21 | ||
| Altman-Z | 7.92 |
ROIC/WACC0.89
WACC8.68%
2.3 Liquidity
A Current Ratio of 13.96 indicates that LMAT has no problem at all paying its short term obligations.
LMAT has a Current ratio of 13.96. This is amongst the best in the industry. LMAT outperforms 98.42% of its industry peers.
LMAT has a Quick Ratio of 11.74. This indicates that LMAT is financially healthy and has no problem in meeting its short term obligations.
LMAT has a better Quick ratio (11.74) than 95.79% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 13.96 | ||
| Quick Ratio | 11.74 |
3. Growth
3.1 Past
LMAT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 23.35%, which is quite impressive.
Measured over the past years, LMAT shows a quite strong growth in Earnings Per Share. The EPS has been growing by 17.13% on average per year.
Looking at the last year, LMAT shows a quite strong growth in Revenue. The Revenue has grown by 14.11% in the last year.
LMAT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.41% yearly.
EPS 1Y (TTM)23.35%
EPS 3Y15.47%
EPS 5Y17.13%
EPS Q2Q%15.38%
Revenue 1Y (TTM)14.11%
Revenue growth 3Y12.5%
Revenue growth 5Y13.41%
Sales Q2Q%15.01%
3.2 Future
LMAT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.76% yearly.
Based on estimates for the next years, LMAT will show a quite strong growth in Revenue. The Revenue will grow by 9.67% on average per year.
EPS Next Y20.02%
EPS Next 2Y14.31%
EPS Next 3Y13.26%
EPS Next 5Y9.76%
Revenue Next Year13.91%
Revenue Next 2Y11.23%
Revenue Next 3Y11.24%
Revenue Next 5Y9.67%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
LMAT is valuated quite expensively with a Price/Earnings ratio of 47.12.
LMAT's Price/Earnings ratio is a bit cheaper when compared to the industry. LMAT is cheaper than 70.00% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.03, LMAT is valued quite expensively.
Based on the Price/Forward Earnings ratio of 38.30, the valuation of LMAT can be described as expensive.
Based on the Price/Forward Earnings ratio, LMAT is valued a bit cheaper than the industry average as 70.53% of the companies are valued more expensively.
LMAT is valuated expensively when we compare the Price/Forward Earnings ratio to 22.63, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 47.12 | ||
| Fwd PE | 38.3 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, LMAT is valued a bit cheaper than 72.11% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, LMAT is valued a bit cheaper than 77.37% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 42.01 | ||
| EV/EBITDA | 26.16 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
LMAT has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as LMAT's earnings are expected to grow with 13.26% in the coming years.
PEG (NY)2.35
PEG (5Y)2.75
EPS Next 2Y14.31%
EPS Next 3Y13.26%
5. Dividend
5.1 Amount
LMAT has a yearly dividend return of 0.84%, which is pretty low.
LMAT's Dividend Yield is rather good when compared to the industry average which is at 1.73. LMAT pays more dividend than 91.58% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.32, LMAT's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.84% |
5.2 History
On average, the dividend of LMAT grows each year by 13.60%, which is quite nice.
LMAT has been paying a dividend for at least 10 years, so it has a reliable track record.
LMAT has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)13.6%
Div Incr Years13
Div Non Decr Years13
5.3 Sustainability
34.45% of the earnings are spent on dividend by LMAT. This is a low number and sustainable payout ratio.
LMAT's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP34.45%
EPS Next 2Y14.31%
EPS Next 3Y13.26%
97.07
+2.51 (+2.65%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners95.69%
Inst Owner Change-2.07%
Ins Owners8.54%
Ins Owner Change-8.31%
Market Cap2.20B
Analysts76.47
Price Target106.87 (10.1%)
Short Float %6.05%
Short Ratio7.59
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.84% |
Yearly Dividend0.64
Dividend Growth(5Y)13.6%
DP34.45%
Div Incr Years13
Div Non Decr Years13
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.86%
Min EPS beat(2)-5.52%
Max EPS beat(2)3.81%
EPS beat(4)2
Avg EPS beat(4)1.56%
Min EPS beat(4)-5.52%
Max EPS beat(4)10.44%
EPS beat(8)6
Avg EPS beat(8)4.62%
EPS beat(12)8
Avg EPS beat(12)3.08%
EPS beat(16)8
Avg EPS beat(16)-1.76%
Revenue beat(2)2
Avg Revenue beat(2)1.31%
Min Revenue beat(2)0.79%
Max Revenue beat(2)1.83%
Revenue beat(4)3
Avg Revenue beat(4)0.17%
Min Revenue beat(4)-2.38%
Max Revenue beat(4)1.83%
Revenue beat(8)4
Avg Revenue beat(8)-0.31%
Revenue beat(12)6
Avg Revenue beat(12)-0.07%
Revenue beat(16)7
Avg Revenue beat(16)-0.44%
PT rev (1m)0.27%
PT rev (3m)0.27%
EPS NQ rev (1m)5.28%
EPS NQ rev (3m)6.23%
EPS NY rev (1m)6%
EPS NY rev (3m)5.34%
Revenue NQ rev (1m)2.15%
Revenue NQ rev (3m)3.97%
Revenue NY rev (1m)2.14%
Revenue NY rev (3m)2.41%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 47.12 | ||
| Fwd PE | 38.3 | ||
| P/S | 9.37 | ||
| P/FCF | 42.01 | ||
| P/OCF | 37.4 | ||
| P/B | 6.06 | ||
| P/tB | 8.34 | ||
| EV/EBITDA | 26.16 |
EPS(TTM)2.06
EY2.12%
EPS(NY)2.53
Fwd EY2.61%
FCF(TTM)2.31
FCFY2.38%
OCF(TTM)2.6
OCFY2.67%
SpS10.36
BVpS16.02
TBVpS11.64
PEG (NY)2.35
PEG (5Y)2.75
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.16% | ||
| ROE | 12.99% | ||
| ROCE | 10.02% | ||
| ROIC | 7.7% | ||
| ROICexc | 18.52% | ||
| ROICexgc | 32.83% | ||
| OM | 23.34% | ||
| PM (TTM) | 20.08% | ||
| GM | 69.11% | ||
| FCFM | 22.3% |
ROA(3y)7.77%
ROA(5y)8.17%
ROE(3y)10.28%
ROE(5y)10.74%
ROIC(3y)8.26%
ROIC(5y)8.93%
ROICexc(3y)14.32%
ROICexc(5y)13.54%
ROICexgc(3y)28.83%
ROICexgc(5y)29.82%
ROCE(3y)10.75%
ROCE(5y)11.62%
ROICexcg growth 3Y-0.4%
ROICexcg growth 5Y7.52%
ROICexc growth 3Y9.22%
ROICexc growth 5Y8.43%
OM growth 3Y0.27%
OM growth 5Y5.61%
PM growth 3Y4.76%
PM growth 5Y5.57%
GM growth 3Y1.48%
GM growth 5Y0.13%
F-Score5
Asset Turnover0.41
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.46 | ||
| Debt/FCF | 3.21 | ||
| Debt/EBITDA | 2.59 | ||
| Cap/Depr | 63.73% | ||
| Cap/Sales | 2.74% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 90.57% | ||
| Profit Quality | 111.05% | ||
| Current Ratio | 13.96 | ||
| Quick Ratio | 11.74 | ||
| Altman-Z | 7.92 |
F-Score5
WACC8.68%
ROIC/WACC0.89
Cap/Depr(3y)60.87%
Cap/Depr(5y)52.43%
Cap/Sales(3y)2.97%
Cap/Sales(5y)2.88%
Profit Quality(3y)96.62%
Profit Quality(5y)110.46%
High Growth Momentum
Growth
EPS 1Y (TTM)23.35%
EPS 3Y15.47%
EPS 5Y17.13%
EPS Q2Q%15.38%
EPS Next Y20.02%
EPS Next 2Y14.31%
EPS Next 3Y13.26%
EPS Next 5Y9.76%
Revenue 1Y (TTM)14.11%
Revenue growth 3Y12.5%
Revenue growth 5Y13.41%
Sales Q2Q%15.01%
Revenue Next Year13.91%
Revenue Next 2Y11.23%
Revenue Next 3Y11.24%
Revenue Next 5Y9.67%
EBIT growth 1Y20%
EBIT growth 3Y12.81%
EBIT growth 5Y19.77%
EBIT Next Year37.11%
EBIT Next 3Y21.1%
EBIT Next 5YN/A
FCF growth 1Y176.09%
FCF growth 3Y7.14%
FCF growth 5Y28.96%
OCF growth 1Y129.52%
OCF growth 3Y7.93%
OCF growth 5Y25.49%